ASCO 2022: Focus on GVHD
In a meta-analysis presented at the 2022 American Society of Clinical Oncology Annual Meeting, researchers evaluated ...
According to research presented at the 2022 American Society of Clinical Oncology Annual Meeting, graft-versus-host ...
Hispanic patients had a significantly lower cumulative incidence of chronic graft-versus-host disease (GVHD) than ...
The first-in-human, phase I clinical trial of ADI-001, an allogeneic gamma delta chimeric antigen receptor (CAR) T-cell ...
A study presented at the 2022 American Society of Clinical Oncology Annual Meeting reported on results of a literature ...
Patients who received an allogeneic hematopoietic stem cell transplant (HSCT) from matched related donors (MRD) or ...
A study presented at the 2022 American Society of Clinical Oncology Annual Meeting found that an autologous CD7 chimeric ...
A retrospective study found that partially mismatched blood or marrow transplantation with post-transplantation ...
Advertisement
Advertisement
